Med Spa Industry Statistics 2026: Revenue, Margins, Growth, and Marketing Benchmarks

Every med spa owner makes decisions based on gut feel until they see the actual numbers. This post is the actual numbers.

We compiled the most current data from AmSpa, Grand View Research, Guidepoint Qsight, Growth99, CorralData, BizMetricsHQ, and other industry sources into a single reference. Market size, revenue per location, profit margins, patient economics, marketing benchmarks, treatment rankings, and startup costs. All in one place, all sourced, all current.

Bookmark this page. You will come back to it.

U.S. med spa market size and growth

The U.S. med spa industry hit $17 billion in 2026 (AmSpa). There are now 10,488 med spa locations operating across the country, up 17.9% from 8,899 the year prior. Of those, 18% opened within the past year alone, adding roughly 1,888 new locations to the market.

The global medical spa market reached $24.2 billion (Grand View Research 2025) and is projected to grow at a 15.9% compound annual growth rate. That is faster than most healthcare verticals and faster than the broader wellness industry.

What does this mean for individual practice owners? Two things. First, the total addressable market is growing, which means more patients are entering the aesthetic market every quarter. Second, competition is growing just as fast. Nearly 1 in 5 med spa locations opened in the last 12 months. If your marketing is not keeping pace, those new locations are absorbing patients who would have found you.

Revenue benchmarks per location

The average U.S. med spa generates $1,398,833 in annual revenue (AmSpa 2024 State of the Industry). That number represents the full range, from startups in their first year to mature multi-provider practices.

The underlying metrics that produce that number:

• 245 patient visits per month on average
• $527 average spend per visit
• 73% repeat-patient share, up from 65% the prior year

That repeat-patient number is significant. Practices with high rebooking rates generate more revenue from lower marketing spend because existing patients cost nothing to acquire on the second, third, and fourth visit. A practice running at 73% repeat visits is spending a fraction of what a 50% repeat-visit practice spends on acquisition to produce the same revenue.

If your revenue per location is below the $1.4M average, the problem is almost always one of three things: not enough new patients, not enough repeat visits, or average transaction values below $500. Our LTV calculator can help you isolate which lever matters most.

Profit margins: the numbers that matter

Average med spa gross margins run 50% to 65% (inclusive of supplies and labor). Net profit margins land between 15% and 25% after all expenses. Median EBITDA across a sample of 120+ med spas is approximately 24% (BizMetricsHQ).

The spread is wide. Top-10% performers clear 32% to 38% EBITDA. The bottom quartile operates at single-digit net margins, working harder every month with less to show for it. Read our full breakdown in the med spa profit margins guide.

Med spas outperform most comparable healthcare verticals on margin percentage. The combination of high-margin consumable treatments, recurring patient relationships, and relatively low overhead compared to surgical practices creates a favorable economic structure. The practices that fail to capitalize on that structure almost always underinvest in the systems that drive retention and acquisition.

¶The injectable margin paradox

Injectable-only practices look profitable on paper. Neurotoxins carry 60% to 70% treatment gross margins. But the whole-practice picture tells a different story: injectable-only practices often net only 8% to 12% after overhead, because they lack the high-margin ancillary treatments (HydraFacials, chemical peels, laser services) that spread fixed costs across a wider revenue base.

Dermal fillers are the lowest-margin injectable category at 40% to 60% gross. A practice built around fillers without diversification is structurally limited on profitability. The fix is not to stop offering fillers. It is to build a treatment mix that balances high-frequency, moderate-margin injectables with lower-frequency, high-margin device and skin treatments.

Use our profit margin calculator to model how your treatment mix stacks up.

Patient economics: LTV, retention, and acquisition cost

Understanding what a patient is worth over time, what it costs to acquire one, and how long they stay changes every marketing and operational decision you make.

¶Lifetime value and spend

• Average patient LTV (modeled): $3,283 (Guidepoint Qsight)
• Average annual spend per patient: $1,576
• Median transaction value: $216 (Zenoti); top 10% of transactions: $484

That $3,283 LTV number is the anchor for everything else. If your cost to acquire a new patient is $200 and their lifetime value is $3,283, you have a 16:1 return on that acquisition cost. If your cost is $400, you still have an 8:1 return. Either number justifies aggressive patient acquisition spending, which is why the practices that grow fastest are almost never the ones spending the least on marketing.

Calculate your practice-specific LTV with our lifetime value calculator.

¶Retention and rebooking

• Annual retention (cohort-based): 52%
• Immediate rebooking rate: 40% average; top performers reach ~70%
• Dormant database share: 25% to 40% of total patient records are inactive

A 52% annual retention rate means nearly half of your patients do not return within a year. That is not a marketing failure in isolation. It is a systems failure. The practices running 70% immediate rebooking rates have automated rebooking prompts, membership programs that create return incentives, and Boomerang™ campaigns that reactivate dormant patients before they forget your name.

That 25% to 40% dormant database is money sitting in your CRM. Those patients already know you, already trusted you, already spent money with you. Boomerang™ campaigns targeting lapsed patients consistently produce the lowest cost-per-acquisition of any marketing channel.

¶Acquisition cost by channel

• Google Ads: $40 to $80 cost per lead
• Meta Ads: $15 to $50 cost per lead
• SEO: $8 to $20 cost per lead after maturity
• Email marketing: $1 to $5 cost per lead
• Direct mail: $12 to $24 per response (3% to 5% response rate)
• Referrals: $10 to $25 cost per lead (13% to 22% conversion rate)
• Industry average (blended): $132 (Growth99) to $285 (First Page Sage)

The gap between $132 and $285 blended cost per acquisition is not random. It reflects how well a practice diversifies its channels. Practices over-reliant on a single paid channel skew toward the $285 end. Practices with mature SEO, active email marketing, and systematic referral programs pull the average down toward $132.

Referrals deserve special attention: 42% to 47% of new med spa patients come from referrals. A practice without a formal referral program is leaving its largest acquisition channel to chance.

Marketing benchmarks: the investment gap

The average med spa spends 7% of revenue on marketing (AmSpa). On $1.4 million in revenue, that is $98,000 per year, or roughly $8,200 per month. That is the average.

The reality for most practices is worse. According to Growth99, 52% of med spas spend under $2,500 per month on marketing, and only 25% reach $5,000 per month. That means over half the industry is investing less than $30,000 per year in patient acquisition and retention while operating in a market that added 1,888 new competitors in the last 12 months.

¶ROI by channel

Email marketing delivers the highest dollar-for-dollar return at $36 to $42 per $1 spent, but it only works on patients already in your database. SEO produces the lowest cost per lead after a 6-to-12-month maturity period, and it compounds over time. Google Ads produces the most predictable, immediate patient flow. Meta Ads produce the highest volume of leads at the lowest per-lead cost, but require optimization to convert at scale.

No single channel is the answer. The highest-performing practices layer all of them. See our full breakdown in the med spa marketing budget guide and model your own allocation with the ad spend calculator.

Membership program economics

Roughly 85% of med spas now offer some form of membership program (Portrait Care). Memberships have become the default operating model for practices focused on predictable recurring revenue and patient retention.

¶The membership advantage

Data from CorralData's H1 2026 analysis (100+ brands, ~500 locations, $500M in revenue) puts hard numbers behind what most practice owners already sense:

• Average monthly membership fee: $89 (SpaLens)
• Members spend 2.5x more than non-members
• 35 percentage-point retention advantage for members over non-members
• Member LTV: ~$5,166 vs. $1,495 for non-members (3.5x higher)
• Membership sales growth: +24% in 2024, +13% in 2025

That 3.5x LTV difference is the single most important number in this section. A non-member patient is worth $1,495 over their relationship with your practice. A member is worth $5,166. Every patient you convert to membership is worth an incremental $3,671 in lifetime revenue.

If you are not running a membership program, start. If you are, optimize. Read our guides on med spa membership programs and membership economics, then model your specific numbers with the membership revenue calculator.

Treatment revenue rankings and margins

The treatment landscape shifted in 2025, and the shifts accelerated into 2026. Here is where revenue stands by category (Qsight 2025).

¶Revenue by treatment category

The fastest-growing category is mechanical microneedling at +33%. Professional skincare grew 9%. Non-EBD rejuvenation (chemical peels, PRP/PRF, and similar treatments) grew 10%.

The declines are equally telling. HA fillers dropped 11%. GLP-1 revenue fell 22% in Q1 2026, signaling that the weight-loss boom may be plateauing as compounding pharmacies face regulatory pressure and patient demand normalizes.

Practices built around a single high-revenue category are exposed to these swings. The practices that weather category shifts are the ones with diversified treatment menus and marketing strategies that can shift emphasis across categories quarter by quarter.

¶Gross margins by treatment

HydraFacial at 85% gross margin is the highest-margin treatment in the typical med spa menu. The device cost is amortized over hundreds of treatments, consumable cost per session is low, and treatment time is predictable. IPL, laser hair removal, and CoolSculpting follow the same pattern: high upfront device investment, low per-treatment variable cost.

Dermal fillers sit at the bottom. Product cost per syringe is high, the margin between wholesale and retail is compressed, and filler procedures require more provider time than neurotoxin injections. This does not mean fillers are bad for your practice. It means fillers should not be your margin driver. They serve as a patient acquisition and retention tool. The margin comes from the HydraFacials, laser treatments, and membership fees that those filler patients add to their treatment plans over time.

Startup costs in 2026

Opening a med spa in 2026 costs more than it did two years ago. Construction costs increased 4.4% year over year (Rider Levett Bucknall), and healthcare staff compensation rose 4.3%. Here is where startup investment ranges land by practice model.

The lean injectable model is the lowest barrier to entry, but as the margin data above shows, it is also the model most likely to get stuck at single-digit net margins. The standard 3-to-4-room build gives enough treatment diversity to reach the 15% to 25% net margin range. Full-service and flagship builds require higher patient volume to justify the investment, but they produce the highest revenue ceilings.

For a detailed cost breakdown by line item, use our startup cost calculator. If you are in the planning stage, our how to open a med spa guide walks through every decision from entity formation to grand opening marketing.

What these numbers mean for your practice

Industry benchmarks are reference points, not targets. A practice generating $800,000 in revenue should not assume $1.4 million is the ceiling. A practice at 15% net margin should not assume 25% is out of reach.

The data points to three structural advantages that separate top-performing practices from the middle of the pack:

1. Diversified treatment menus. Practices that combine high-frequency injectables with high-margin device treatments and recurring membership revenue outperform single-category practices on both revenue and margin. The injectable margin paradox is real. Diversification solves it.

2. Multi-channel marketing. The 52% of practices spending under $2,500 per month are not just underspending. They are almost certainly under-diversified, relying on one or two channels. The practices reaching 5x to 10x ROI are layering SEO, Google Ads, Meta Ads, email, reputation management, and Boomerang™ campaigns into a system where each channel reinforces the others.

3. Membership as the operating model. The 3.5x LTV difference between members and non-members is too large to ignore. Membership is not a loyalty perk. It is an economic structure that changes every downstream metric: retention, visit frequency, annual spend, and acquisition cost payback.

If you want to know where your practice stands against these benchmarks, and which levers will produce the fastest improvement, schedule a strategy session. Pronk MedSpa Marketing works with one practice per city. No commitment required. No credit card.